Cox & Kings plans global expansion into the US and Australia under Abercrombie & Kent Travel Group leadership.

New research suggests the adult brain can be convinced to grow new neurons to replace those lost in Huntington’s disease. The ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended ...

Globus continues to enhance the options travelers have on a tour with Globus Choice touring. The Globus Choice program is positioned to address a growing trend among travelers who seek the convenience ...

BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in the MedTech space.

Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Globus Medical (GMED), which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider. This medical device company has seen a nice streak of beating earnings ...

Globus Spirits, operating in the Beverages & Distilleries sector and classified as a Smallcap on the BSE, currently has its share price at ₹1070.5. The stock has experienced fluctuations today ...